MedRhythms Advances Pipeline of Neurologic Rehabilitation Products in Multiple Sclerosis, Parkinson’s Disease

January 15, 2020

MedRhythms, a prescription digital therapeutics company, assembles Scientific Advisory Boards for multiple sclerosis and Parkinson's disease with world-leading researchers, and a study of the Company's multiple sclerosis pipeline product (MR-004) to be launched

(Reprint from CISION PR Newswire 1/14/2020) PORTLAND, Maine, Jan. 14, 2020 /PRNewswire/ — MedRhythms, a Portland, Maine-based digital therapeutics company that uses sensors, software, and music to measure and improve walking, today announced the advancement of its pipeline in multiple sclerosis (MS) and Parkinson’s disease (PD). Read more here.